ClinVar Miner

Submissions for variant NM_001369.3(DNAH5):c.10473G>A (p.Thr3491=)

gnomAD frequency: 0.34838  dbSNP: rs2401809
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000150467 SCV000197653 benign not specified 2013-02-21 criteria provided, single submitter clinical testing Thr3491Thr in exon 62 of DNAH5: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 36.4% (3128/8600) of European American chromosomes from a broad population by the NHLBI Exome Sequ encing Project (http://evs.gs.washington.edu/EVS; dbSNP rs2401809).
PreventionGenetics, part of Exact Sciences RCV000150467 SCV000307664 benign not specified criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001094976 SCV000453057 benign Primary ciliary dyskinesia 3 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV000346569 SCV001000243 benign Primary ciliary dyskinesia 2024-02-01 criteria provided, single submitter clinical testing
Pars Genome Lab RCV001094976 SCV001738561 benign Primary ciliary dyskinesia 3 2021-06-15 criteria provided, single submitter clinical testing
GeneDx RCV001705988 SCV001830222 benign not provided 2018-12-19 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001094976 SCV001875589 benign Primary ciliary dyskinesia 3 2021-07-30 criteria provided, single submitter clinical testing
Ambry Genetics RCV000346569 SCV002709471 benign Primary ciliary dyskinesia 2014-11-26 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Breakthrough Genomics, Breakthrough Genomics RCV001705988 SCV005305998 benign not provided criteria provided, single submitter not provided
Natera, Inc. RCV000346569 SCV001452263 benign Primary ciliary dyskinesia 2020-09-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.